HKPD
Hong Kong Pharma Digital Technology Holdings Limited Ordinary sharesKey Statistics
About Hong Kong Pharma Digital Technology Holdings Limited Ordinary shares
Hong Kong Pharma Digital Technology Holdings Limited is a pioneering company at the intersection of biotechnology and digital healthcare, focusing on the integration of cutting-edge technology with pharmaceutical services to enhance patient outcomes and streamline healthcare delivery. Leveraging advanced digital solutions and data analytics, the company optimizes drug development processes and improves operational efficiencies, positioning itself as a critical player in the evolving healthcare landscape. With a strong commitment to health technology advancement and the cultivation of strategic alliances, Hong Kong Pharma is poised to meet the demands of both domestic and global markets while driving innovation across its pharmaceutical service offerings.
Fundamentals
| Revenue (TTM) | $16.36M |
| Gross Profit (TTM) | $1.44M |
| EBITDA | -534,478 |
| Operating Margin | 2.96% |
| Return on Equity | -13.40% |
| Return on Assets | -3.94% |
| Revenue/Share (TTM) | $1.53 |
| Book Value | $0.47 |
| Price-to-Book | 2.60 |
| Price-to-Sales (TTM) | 0.75 |
| EV/Revenue | 0.805 |
| EV/EBITDA | 30.51 |
| Quarterly Earnings Growth (YoY) | -83.10% |
| Quarterly Revenue Growth (YoY) | -35.70% |
| Shares Outstanding | $16.35M |
| Float | $7.36M |
| % Insiders | 62.26% |
| % Institutions | 0.36% |